These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 17643334)

  • 1. The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule.
    Keystone JS; Hershey JH
    Int J Infect Dis; 2008 Jan; 12(1):3-11. PubMed ID: 17643334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years.
    Kurugöl Z; Mutlubaş F; Ozacar T
    Vaccine; 2005 Apr; 23(22):2876-80. PubMed ID: 15780736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
    González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
    Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
    Connor BA; Blatter MM; Beran J; Zou B; Trofa AF
    J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
    Van Damme P; Van Herck K
    Expert Rev Vaccines; 2004 Jun; 3(3):249-67. PubMed ID: 15176942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and factors associated with self-reported vaccination rates among US adults at high risk of vaccine-preventable hepatitis.
    Chen H; Cantrell CR
    Curr Med Res Opin; 2006 Dec; 22(12):2489-96. PubMed ID: 17257463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The A's and B's of vaccine-preventable hepatitis: improving prevention in high-risk adults.
    Oldfield EC; Keeffe EB
    Rev Gastroenterol Disord; 2007; 7(1):1-21. PubMed ID: 17392626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunization against viral hepatitis: an obligatory recommendation in consults for sexually transmitted diseases].
    García-Doval I
    Actas Dermosifiliogr; 2007 Mar; 98(2):88-90. PubMed ID: 17397593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with hepatitis A and B vaccines.
    Davis JP
    Am J Med; 2005 Oct; 118 Suppl 10A():7S-15S. PubMed ID: 16271535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twinrix vaccination schedules among injecting drug users.
    Brim N; Zaller N; Taylor LE; Feller E
    Expert Opin Biol Ther; 2007 Mar; 7(3):379-89. PubMed ID: 17309329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
    Jaber SM
    Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
    Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a hepatitis A/B vaccination program using an accelerated schedule among high-risk inmates, Los Angeles County Jail, 2007-2010.
    Costumbrado J; Stirland A; Cox G; El-Amin AN; Miranda A; Carter A; Malek M
    Vaccine; 2012 Nov; 30(48):6878-82. PubMed ID: 22989688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children.
    Roberton D; Marshall H; Nolan TM; Sokal E; Díez-Domingo J; Flodmark CE; Rombo L; Lewald G; Flor Jde L; Casanovas JM; Verdaguer J; Marés J; Esso DV; Dieussaert I; Stoffel M
    Vaccine; 2005 Oct; 23(43):5099-105. PubMed ID: 16055231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine.
    Beran J
    Expert Rev Vaccines; 2007 Dec; 6(6):891-902. PubMed ID: 18377352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of hepatitis A and hepatitis B by vaccination].
    Buisson Y; Meyran M
    Ann Gastroenterol Hepatol (Paris); 1995 Oct; 31(5):306-8; discussion 308-9. PubMed ID: 8572566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adults.
    Van Herck K; Leroux-Roels G; Van Damme P; Srinivasa K; Hoet B
    Travel Med Infect Dis; 2007 May; 5(3):171-5. PubMed ID: 17448944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9-10 year-old girls according to 0-6 month schedule.
    Gilca V; Sauvageau C; Boulianne N; De Serres G; Couillard M; Krajden M; Ouakki M; Murphy D; Trevisan A; Dionne M
    Hum Vaccin Immunother; 2014; 10(8):2438-45. PubMed ID: 25424952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of accelerated and rapid schedules for monovalent hepatitis B and combined hepatitis A/B vaccines in children with cancer.
    Köksal Y; Varan A; Aydin GB; Sari N; Yazici N; Yalcin B; Kutluk T; Akyuz C; Büyükpamukçu M
    Pediatr Hematol Oncol; 2007 Dec; 24(8):587-94. PubMed ID: 18092249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.